Infection with Conditionally Virulent Streptococcus pneumoniae Δ pab Strains Induces Antibody to Conserved Protein Antigens but Does Not Protect against Systemic Infection with Heterologous Strains
Authors:
- 1 December 2011
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 79 (12) , 4965-4976
Abstract
Avirulent strains of a bacterial pathogen could be useful tools for investigating immunological responses to infection and potentially effective vaccines. We have therefore constructed an auxotrophic TIGR4 Δ pab strain of Streptococcus pneumoniae by deleting the pabB gene Sp_0665. The TIGR4 Δ pab strain grew well in complete medium but was unable to grow in serum unless it was supplemented with para -aminobenzoic acid (PABA). The TIGR4 Δ pab strain was markedly attenuated in virulence in mouse models of S. pneumoniae nasopharyngeal colonization, pneumonia, and sepsis. Supplementing mouse drinking water with PABA largely restored the virulence of TIGR4 Δ pab . An additional Δ pab strain constructed in the D39 capsular serotype 2 background was also avirulent in a sepsis model. Systemic inoculation of mice with TIGR4 Δ pab induced antibody responses to S. pneumoniae protein antigens, including PpmA, PsaA, pneumolysin, and CbpD, but not capsular polysaccharide. Flow cytometry demonstrated that IgG in sera from TIGR4 Δ pab -vaccinated mice bound to the surface of TIGR4 and D39 bacteria but not to a capsular serotype 3 strain, strain 0100993. Mice vaccinated with the TIGR4 Δ pab or D39 Δ pab strain by intraperitoneal inoculation were protected from developing septicemia when challenged with the homologous S. pneumoniae strain. Vaccination with the TIGR4 Δ pab strain provided only weak or no protection against heterologous challenge with the D39 or 0100993 strain but did strongly protect against a TIGR4 capsular-switch strain expressing a serotype 2 capsule. The failure of cross-protection after systemic vaccination with Δ pab bacteria suggests that parenteral administration of a live attenuated vaccine is not an attractive approach for preventing S. pneumoniae infection.Keywords
This publication has 44 references indexed in Scilit:
- Development of a multiplexed bead-based immunoassay for the simultaneous detection of antibodies to 17 pneumococcal proteinsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2010
- Options for Inactivation, Adjuvant, and Route of Topical Administration of a Killed, Unencapsulated Pneumococcal Whole-Cell VaccineClinical and Vaccine Immunology, 2010
- Interaction of Pneumococcal Histidine Triad Proteins with Human ComplementInfection and Immunity, 2010
- Streptococcus pneumoniae Resistance to Complement-Mediated Immunity Is Dependent on the Capsular SerotypeInfection and Immunity, 2010
- Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimatesThe Lancet, 2009
- Pathogen Recognition and Inflammatory Signaling in Innate Immune DefensesClinical Microbiology Reviews, 2009
- Maturation of Streptococcus pneumoniae lipoproteins by a type II signal peptidase is required for ABC transporter function and full virulenceMolecular Microbiology, 2007
- Live Attenuated Streptococcus pneumoniae Strains Induce Serotype-Independent Mucosal and Systemic Protection in MiceInfection and Immunity, 2007
- Characterization of the Role of para- Aminobenzoic Acid Biosynthesis in Folate Production by Lactococcus lactisApplied and Environmental Microbiology, 2007
- Streptococcus pneumoniae Pilus Subunits Protect Mice against Lethal ChallengeInfection and Immunity, 2007